Replies to post #264815 on NorthWest Biotherapeutics Inc (NWBO)

[tryn2]

Flip, l really respect your opinions on this board.... but even though we are ‘invested’ in NWBO, l really believe the management of NWBO is “all in” with this treatment, and are both apprehensive and incredibly conservative with respect to unblinding this trial at the optimum moment. My take is that they are aware of how important this one moment is, and may be overly cautious because of it... even though the comment period “MAY” be over, they are still waiting just in case... and at some point they are just going to have to takes deep breath and pull the trigger... and we are all going to have to wait until then...

Then again, they may still be in a “ back and forth” with the RA’s...

[Hbpainter]

I think there could be unnecessary treatment delay and/or inadequate communication to investors. If I’m wrong NWBO has nothing to fear from any possible regulatory review. Nothing.

In the 4.5 years I've been invested it's always been crap communication, timelines, all of it, for possible reasons gone over endlessly. I believe TLD will be released and that it will do investors and patients well. How on earth is attempting to bring regulatiors into the mix, going to help patients, investors or the company achieve the goal all decent people desire?